Skip to content
Novabase Plus

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Deal Over Information Apprehensions

Medical funding image
The proposed American financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' request for sensitive biological samples.

The decision became public after a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "skewed".

An official representative has since clarified that the United States was requesting health data for research and profit while was unwilling to share the resulting advantages from future vaccines.

"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has appealed for more negotiations to secure a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.

Wider Implications

This development comes after a comparable case in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were raised about the security of citizens' medical information.

After returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and responsibility.

As per reports, Sixteen nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in committed funds.

Specifics of the Declined Deal

The money for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"Effectively, our country would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our population should a future pandemic arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending structures previously set up through the international health agency.

Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.

"This mechanism is designed to ensure that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.

"We encourage ongoing discussions with our US partners on how subsequent collaboration might be arranged in a manner that respects the independence and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but suggested that negotiations must proceed given that much of the nation's Aids initiatives relied on foreign aid.

"If technical issues arise, including those involving information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group commented.

The halted deal underscores the complex tensions between accepting crucial international aid and protecting local interests in an ever more data-driven world.

The writer

Diana Rubio

Lena is a seasoned digital marketer with 8 years of experience helping Dutch brands grow online.

Novabase Plus

Type to search articles.